Dr. Linda Pullan

Holds a PhD in biochemistry
Has 20+ years of industry experience, starting in drug discovery at Monsanto/Searle/Pfizer and ICI/Zeneca/AstraZeneca
Led teams that put Seroquel, a multi-billion-dollar antipsychotic, and other molecules into development
Business development background with in-licensing technology and early drug candidates at AstraZeneca; head of oncology hematology licensing for Amgen
Former Vice-President of Business Development at Kosan Biosciences
Has taught business development for several companies, and served as a grant reviewer for the Australian Medical Research Fund
Has served as CEO and on boards for several small companies and for the AUTM Foundation
Founder of Pullan Consulting, which helps in all aspects of business development for fundraising and partnering, including outreach, evaluation, valuation, negotiation, and strategy with clients in the U.S., Europe, and Asia
Learn more at Pullan Consulting